Cell cycle-coupled expansion of AR activity promotes cancer progression. by McNair, C, Urbanucci, A, Comstock, C, Augello, M, Goodwin, J, Launchbury, R, Zhao, S, Schiewer, M, Ertel, A, Karnes, J, Davicioni, E, Wang, L, Wang, Q, Mills, I, Feng, F, Li, W, Carroll, J, Knudsen, K

Lipid degradation promotes prostate cancer cell survival. by Itkonen, H, Brown, M, Urbanucci, A, Tredwell, G, Ho Lau, C, Barfeld, S, Hart, C, Guldvik, I, Takhar, M, Heemers, H, Erho, N, Bloch, K, Davicioni, E, Derua, R, Waelkens, E, Mohler, J, Clarke, N, Swinnen, J, Keun, H, Rekvig, O, Mills, I

Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer by Yang, L, Roberts, D, Takhar, M, Erho, N, Bibby, B, Thiruthaneeswaran, N, Bhandari, V, Cheng, W, Haider, S, McCorry, A, McArt, D, Jain, S, Alshalalfa, M, Ross, A, Schaffer, E, Den, R, Jeffrey Karnes, R, Klein, E, Hoskin, P, Freedland, S, Lamb, A, Neal, D, Buffa, F, Bristow, R, Boutros, P, Davicioni, E, Choudhury, A, West, C

Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer. by Urbanucci, A, Barfeld, S, Kytölä, V, Itkonen, H, Coleman, I, Vodák, D, Sjöblom, L, Sheng, X, Tolonen, T, Minner, S, Burdelski, C, Kivinummi, K, Kohvakka, A, Kregel, S, Takhar, M, Alshalalfa, M, Davicioni, E, Erho, N, Lloyd, P, Karnes, R, Ross, A, Schaeffer, E, Vander Griend, D, Knapp, S, Corey, E, Feng, F, Nelson, P, Saatcioglu, F, Knudsen, K, Tammela, T, Sauter, G, Schlomm, T, Nykter, M, Visakorpi, T, Mills, I